ArticleHealthcare technology letters
ELW-CNN: An extremely lightweight convolutional neural network for enhancing interoperability in colon and lung cancer identification using explainable AI.
Article in Healthcare technology letters. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Clinical validation of lightweight CNN architectures for reliable multi-class classification of lung cancer using histopathological imaging techniques.Scientific reports · 2026Article
- Compact deep learning models for colon histopathology focusing performance and generalization challenges.Scientific reports · 2026Article
- Review
- ELW-CNN: An extremely lightweight convolutional neural network for enhancing interoperability in colon and lung cancer identification using explainable AI.Healthcare technology lettersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a condition in which cells in the body grow uncontrollably, often forming tumours and potentially spreading to various areas of the body. Cancer is a hazardous medical case in medical history analysis. Every year, many people die of cancer at an early stage. Therefore, it is necessary to accurately and early identify cancer to effectively treat and save human lives. However, various machine and deep learning models are effective for cancer identification. Therefore, the effectiveness of these efforts is limited by the small dataset size, poor data quality, interclass changes between lung squamous cell carcinoma and adenocarcinoma, difficulties with mobile device deployment, and lack of image and individual-level accuracy tests. To overcome these difficulties, this study proposed an extremely lightweight model using a convolutional neural network that achieved 98.16% accuracy for a large lung and colon dataset and individually achieved 99.02% for lung cancer and 99.40% for colon cancer. The proposed lightweight model used only 70 thousand parameters, which is highly effective for real-time solutions. Explainability methods such as Grad-CAM and symmetric explanation highlight specific regions of input data that affect the decision of the proposed model, helping to identify potential challenges. The proposed models will aid medical professionals in developing an automated and accurate approach for detecting various types of colon and lung cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.